- Annual Report & AGM Notice
- Significant POLB 001 Patent Granted in USA
- Appointment of Joint Broker
- Option Agreement to Acquire Orphan Drug Candidate
- Results for the year ended 31 December 2023
- TR-1: Notification of major holdings
- POLB 001 US Patent Update
- Director/PDMR Shareholding
- Director Share Purchase
- Board Role Change and Launch of EIP
More ▼
Key statistics
On Wednesday, Poolbeg Pharma PLC (POLB:LSE) closed at 13.20, -16.28% below its 52-week high of 15.77, set on May 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.50 |
---|---|
High | 12.50 |
Low | 12.45 |
Bid | 12.50 |
Offer | 13.50 |
Previous close | 13.20 |
Average volume | 1.73m |
---|---|
Shares outstanding | 500.00m |
Free float | 386.69m |
P/E (TTM) | -- |
Market cap | 62.50m GBP |
EPS (TTM) | -0.0079 GBP |
Data delayed at least 20 minutes, as of May 22 2024 16:31 BST.
More ▼